Stephen T Zarrilli

CIK 1203410 · View on SEC EDGAR ↗

Insider

First SEC filing: March 7, 2024 · Latest: March 7, 2024

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.

Insider at

Insider transactions

0 buys (P) 2 sells (S) Net: $-4,283,250 + 22 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

22 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Aug. 18, 2026	GMED	M	25,000	$53.27	$1,331,750	25,000 Direct	—	Acquired	65.6% (price as of 2026-08-20)
Aug. 18, 2026	GMED	S	25,000	$87.04	$2,176,000	0 Direct	-100.00%	Disposed	1.3% (price as of 2026-08-20)
Aug. 18, 2026	GMED	M	25,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Jan. 21, 2026	GMED	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 11, 2025	GMED	M	25,000	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Nov. 11, 2025	GMED	S	25,000	$84.29	$2,107,250	0 Direct	-100.00%	Disposed	4.7% (price as of 2026-08-20)
Nov. 11, 2025	GMED	M	25,000	$44.14	$1,103,500	25,000 Direct	—	Acquired	99.8% (price as of 2026-08-20)
Jan. 23, 2025	GMED	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
March 6, 2024	VRTS	S	2,150	$248.40	$534,060	3,549 Direct	-37.73%	Disposed	-32.4% (price as of 2026-08-20)
Jan. 26, 2024	GMED	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
May 17, 2023	VRTS	A	602	$178.54	$107,481	5,699 Direct	+11.81%	Acquired	-5.9% (price as of 2026-08-20)
Jan. 26, 2023	GMED	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
May 18, 2022	VRTS	A	585	$175.00	$102,375	5,097 Direct	+12.97%	Acquired	-4.0% (price as of 2026-08-20)
Jan. 27, 2022	GMED	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
Aug. 3, 2021	VRTS	S	1,808	$280.55	$507,234	4,512 Direct	-28.61%	Disposed	-40.1% (price as of 2026-08-20)
May 14, 2021	VRTS	A	367	$268.04	$98,371	6,320 Direct	+6.16%	Acquired	-37.3% (price as of 2026-08-20)
Jan. 14, 2021	GMED	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
May 18, 2020	VRTS	A	1,138	$89.16	$101,464	5,953 Direct	+23.63%	Acquired	88.4% (price as of 2026-08-20)
Jan. 22, 2020	GMED	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-20)
May 15, 2019	VRTS	A	902	$117.78	$106,238	4,815 Direct	+23.05%	Acquired	42.6% (price as of 2026-08-20)
May 1, 2019	GMED	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-20)
May 15, 2018	VRTS	A	856	$124.00	$106,144	3,913 Direct	+28.00%	Acquired	35.5% (price as of 2026-08-20)
May 19, 2017	VRTS	A	976	$103.70	$101,211	3,057 Direct	+46.90%	Acquired	62.0% (price as of 2026-08-20)
May 25, 2016	VRTS	A	1,129	$80.81	$91,234	2,081 Direct	+118.59%	Acquired	107.9% (price as of 2026-08-20)
May 28, 2015	VRTS	A	648	$127.25	$82,458	952 Direct	+213.16%	Acquired	32.0% (price as of 2026-08-20)
Oct. 8, 2014	VRTS	A	304	$169.72	$51,595	304 Direct	—	Acquired	-1.0% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Aug. 18, 2026	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (25,000)	$53.27	Jan. 22, 2030	25,000	Disposed
Jan. 21, 2026	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (15,000)	$94.15	Jan. 21, 2036	15,000	Acquired
Nov. 11, 2025	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (25,000)	$44.14	May 1, 2029	25,000	Disposed
Jan. 23, 2025	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (15,000)	$92.42	Jan. 23, 2035	15,000	Acquired
Jan. 26, 2024	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (15,000)	$53.75	Jan. 26, 2034	15,000	Acquired
Jan. 26, 2023	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (15,000)	$75.18	Jan. 26, 2033	15,000	Acquired
Jan. 27, 2022	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (15,000)	$63.68	Jan. 27, 2032	15,000	Acquired
Jan. 14, 2021	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (15,000)	$65.05	Jan. 14, 2031	15,000	Acquired
Jan. 22, 2020	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (25,000)	$53.27	Jan. 22, 2030	25,000	Acquired
May 1, 2019	GMED	Stock Option (Right to Buy Class A Common Stock)	Class A Common Stock (25,000)	$44.14	May 1, 2029	25,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
May 3, 2019	GMED	No securities are beneficially owned	0	Direct